5 Einträge |
Seite 1 / 1
![]() |
Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. |
Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Taipale K, Girvan AC, Visseren-Grul C, Schnabel PA |
Lung cancer (Amsterdam, Netherlands). 2015 Feb 21. pii: S0169-5002(15)00118-X. doi: 10.1016/j.lungcan.2015.02.011 |
PMID: 25748103 |
Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study. |
Smit E, Moro-Sibilot D, Carpeño Jde C, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA |
Lung cancer (Amsterdam, Netherlands). 2015 Dec 3. pii: S0169-5002(15)30118-5. doi: 10.1016/j.lungcan.2015.11.022 |
PMID: 26775594 |
Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study. |
Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA |
Lung cancer (Amsterdam, Netherlands). 2015 Nov 10. pii: S0169-5002(15)30107-0. doi: 10.1016/j.lungcan.2015.11.011 |
PMID: 26791802 |
1252PNSCLC PATIENTS WITH BRAIN METASTASES TREATED WITH PLATINUM-BASED DOUBLETS AS FIRST-LINE THERAPY: ANALYSES FROM THE EUROPEAN FRAME OBSERVATIONAL STUDY. |
Moro-Sibilot D, Smit EF, Carpeño JC, Lesniewski-Kmak K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith K, Girvan A, Visseren-Grul CM, Schnabel PA |
Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241967. doi: 10.1093/annonc/mdu349.31 |
PMID: 28171285 |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
PMID: 29146401 |
5 Einträge |
Seite 1 / 1
![]() |